S&P 500   5,135.96 (-0.26%)
DOW   38,824.00 (+0.09%)
QQQ   433.80 (-0.84%)
AAPL   173.32 (-0.23%)
MSFT   415.76 (-0.37%)
META   483.39 (-2.73%)
GOOGL   146.62 (-0.72%)
AMZN   174.04 (-0.25%)
TSLA   172.00 (-1.04%)
NVDA   859.06 (-2.88%)
NIO   5.38 (-2.89%)
AMD   181.97 (-4.55%)
BABA   73.37 (-0.20%)
T   17.28 (-0.12%)
F   12.25 (+0.57%)
MU   92.16 (-1.73%)
CGC   3.45 (-7.01%)
GE   169.71 (-0.12%)
DIS   113.74 (-0.10%)
AMC   4.35 (-0.91%)
PFE   27.69 (-0.11%)
PYPL   63.62 (-0.95%)
XOM   113.06 (+0.68%)
S&P 500   5,135.96 (-0.26%)
DOW   38,824.00 (+0.09%)
QQQ   433.80 (-0.84%)
AAPL   173.32 (-0.23%)
MSFT   415.76 (-0.37%)
META   483.39 (-2.73%)
GOOGL   146.62 (-0.72%)
AMZN   174.04 (-0.25%)
TSLA   172.00 (-1.04%)
NVDA   859.06 (-2.88%)
NIO   5.38 (-2.89%)
AMD   181.97 (-4.55%)
BABA   73.37 (-0.20%)
T   17.28 (-0.12%)
F   12.25 (+0.57%)
MU   92.16 (-1.73%)
CGC   3.45 (-7.01%)
GE   169.71 (-0.12%)
DIS   113.74 (-0.10%)
AMC   4.35 (-0.91%)
PFE   27.69 (-0.11%)
PYPL   63.62 (-0.95%)
XOM   113.06 (+0.68%)
S&P 500   5,135.96 (-0.26%)
DOW   38,824.00 (+0.09%)
QQQ   433.80 (-0.84%)
AAPL   173.32 (-0.23%)
MSFT   415.76 (-0.37%)
META   483.39 (-2.73%)
GOOGL   146.62 (-0.72%)
AMZN   174.04 (-0.25%)
TSLA   172.00 (-1.04%)
NVDA   859.06 (-2.88%)
NIO   5.38 (-2.89%)
AMD   181.97 (-4.55%)
BABA   73.37 (-0.20%)
T   17.28 (-0.12%)
F   12.25 (+0.57%)
MU   92.16 (-1.73%)
CGC   3.45 (-7.01%)
GE   169.71 (-0.12%)
DIS   113.74 (-0.10%)
AMC   4.35 (-0.91%)
PFE   27.69 (-0.11%)
PYPL   63.62 (-0.95%)
XOM   113.06 (+0.68%)
S&P 500   5,135.96 (-0.26%)
DOW   38,824.00 (+0.09%)
QQQ   433.80 (-0.84%)
AAPL   173.32 (-0.23%)
MSFT   415.76 (-0.37%)
META   483.39 (-2.73%)
GOOGL   146.62 (-0.72%)
AMZN   174.04 (-0.25%)
TSLA   172.00 (-1.04%)
NVDA   859.06 (-2.88%)
NIO   5.38 (-2.89%)
AMD   181.97 (-4.55%)
BABA   73.37 (-0.20%)
T   17.28 (-0.12%)
F   12.25 (+0.57%)
MU   92.16 (-1.73%)
CGC   3.45 (-7.01%)
GE   169.71 (-0.12%)
DIS   113.74 (-0.10%)
AMC   4.35 (-0.91%)
PFE   27.69 (-0.11%)
PYPL   63.62 (-0.95%)
XOM   113.06 (+0.68%)
NYSE:A

Agilent Technologies (A) Stock Price, News & Analysis

$146.95
+0.86 (+0.59%)
(As of 09:46 AM ET)
Today's Range
$145.52
$147.30
50-Day Range
$128.10
$149.36
52-Week Range
$96.80
$151.58
Volume
40,687 shs
Average Volume
1.62 million shs
Market Capitalization
$43.06 billion
P/E Ratio
34.99
Dividend Yield
0.64%
Price Target
$141.31

Agilent Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
3.3% Downside
$141.31 Price Target
Short Interest
Healthy
0.94% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.78
Upright™ Environmental Score
News Sentiment
0.96mentions of Agilent Technologies in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$9.21 M Sold Last Quarter
Proj. Earnings Growth
9.27%
From $5.50 to $6.01 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.70 out of 5 stars

Computer And Technology Sector

24th out of 608 stocks

Analytical Instruments Industry

2nd out of 29 stocks

A stock logo

About Agilent Technologies Stock (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock Price History

A Stock News Headlines

Like Tiny Crypto Retirement Funds
The crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds.
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Assessing Agilent Technologies: Insights From 6 Financial Analysts
Q1 2024 Agilent Technologies Inc Earnings Call
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/24 Dividend
12/29/2023
Dividend Payable
1/24/2024
Last Earnings
2/27/2024
Today
3/19/2024
Ex-Dividend for 4/24 Dividend
4/01/2024
Dividend Payable
4/24/2024
Next Earnings (Estimated)
5/28/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Target
$141.31
High Stock Price Target
$165.00
Low Stock Price Target
$123.00
Potential Upside/Downside
-3.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
16 Analysts

Profitability

Net Income
$1.24 billion
Pretax Margin
19.78%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$6.46 per share
Book Value
$21.11 per share

Miscellaneous

Free Float
N/A
Market Cap
$42.81 billion
Optionable
Optionable
Beta
1.11

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Agilent Technologies was last updated on Wednesday, March 6, 2024 at 8:58 PM.

Pros

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies has been consistently receiving positive ratings from various analysts, with a consensus rating of "Moderate Buy" and an average price target of $141.31, indicating potential growth.
  • Recent upgrades by reputable sources like StockNews.com, TheStreet, and The Goldman Sachs Group suggest a positive outlook for the company's stock performance.
  • Morgan Stanley significantly increased its holdings in Agilent Technologies, indicating confidence in the company's future prospects.
  • Agilent Technologies provides application-focused solutions to diverse markets, including life sciences, diagnostics, and applied chemical sectors, showcasing a broad market presence.
  • The company operates in three segments, offering a wide range of products and services, which can potentially attract a diverse customer base and drive revenue growth.

Cons

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Some analysts have issued a sell rating for the stock, indicating a level of uncertainty or potential risks associated with investing in Agilent Technologies.
  • Barclays recently downgraded the stock to an "underweight" rating, suggesting a cautious approach due to certain factors affecting the company's performance.
  • Bank of America lowered its rating from "buy" to "neutral," which could signal a shift in market sentiment towards Agilent Technologies.
  • Evercore ISI reduced the price target for Agilent Technologies, indicating a more conservative outlook on the stock's future growth potential.
  • Citigroup's price target increase to $145.00 may not align with other analysts' views, leading to potential discrepancies in market expectations for the stock.

A Stock Analysis - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 sell rating, 6 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price target for 2024?

16 brokers have issued 12 month price targets for Agilent Technologies' shares. Their A share price targets range from $123.00 to $165.00. On average, they anticipate the company's share price to reach $141.31 in the next twelve months. This suggests that the stock has a possible downside of 3.3%.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2024?

Agilent Technologies' stock was trading at $139.03 at the beginning of the year. Since then, A shares have increased by 5.1% and is now trading at $146.11.
View the best growth stocks for 2024 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decrease in short interest in February. As of February 29th, there was short interest totaling 2,740,000 shares, a decrease of 14.6% from the February 14th total of 3,210,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is presently 1.7 days. Approximately 0.9% of the shares of the stock are sold short.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024.
View our A earnings forecast
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) released its earnings results on Tuesday, February, 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.07. The medical research company had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a trailing twelve-month return on equity of 27.09% and a net margin of 18.35%. The firm's quarterly revenue was down 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.37 earnings per share.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, February 21st. Stockholders of record on Tuesday, April 2nd will be paid a dividend of $0.236 per share on Wednesday, April 24th. This represents a $0.94 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Monday, April 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.94 per share and currently has a dividend yield of 0.64%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.64% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its board has authorized a stock buyback plan on Monday, January 9th 2023, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 4.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its shares are undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its second quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of 1.170-1.200 for the period, compared to the consensus estimate of 1.270. The company issued revenue guidance of $1.6 billion-$1.6 billion, compared to the consensus revenue estimate of $1.6 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.63%), Vanguard Group Inc. (8.63%), Massachusetts Financial Services Co. MA (4.52%), Wellington Management Group LLP (3.37%), Price T Rowe Associates Inc. MD (2.56%) and Northern Trust Corp (1.36%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Philip Binns, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
This page (NYSE:A) was last updated on 3/19/2024 by MarketBeat.com Staff

From Our Partners